Finding disease-specific coordinated functions by multi-function genes: Insight into the coordination mechanisms in diseases

Genomics

Volumn 94, Issue 2, 2009, Pages 94-100

  Ma, Wencai ^a   Yang, Da ^a   Gu, Yunyan ^a   Guo, Xinwu ^a   Zhao, Wenyuan ^a   Guo, Zheng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Cancer; Disease gene; Gene functions; Gene mutation; Gene ontology; Protein protein interaction

Indexed keywords

ATM PROTEIN; PROTEIN P53; SOMATOMEDIN C RECEPTOR;

ARTICLE; BIOINFORMATICS; CANCER GENETICS; CARDIOMYOPATHY; CONTROLLED STUDY; GENE CONTROL; GENE FUNCTION; GENE MUTATION; PRIORITY JOURNAL;

CARDIOMYOPATHIES; GENE REGULATORY NETWORKS; GENETIC MARKERS; HUMANS; MUTATION; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 67649979842     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.05.001     Document Type: Article

References (50)

1. Kim T., Yoon J., Cho H., Lee W.B., Kim J., Song Y.H., Kim S.N., Yoon J.H., Kim-Ha J., and Kim Y.J. Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat. Immunol. 6 2 (2005) 211-218
2. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 1 (2000) 25-29
3. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 5 (2003) P3
4. Zhu J., Wang J., Guo Z., Zhang M., Yang D., Li Y., Wang D., and Xiao G. GO-2D: identifying 2-dimensional cellular-localized functional modules in Gene Ontology. BMC Genomics 8 (2007) 30
5. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102 43 (2005) 15545-15550
6. Barry W.T., Nobel A.B., and Wright F.A. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 21 9 (2005) 1943-1949
7. Langfelder P., and Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst. Biol. 1 (2007) 54
8. Bandyopadhyay S., Kelley R., Krogan N.J., and Ideker T. Functional maps of protein complexes from quantitative genetic interaction data. PLoS Comput. Biol. 4 4 (2008) e1000065
9. Ulitsky I., and Shamir R. Pathway redundancy and protein essentiality revealed in the Saccharomyces cerevisiae interaction networks. Mol. Syst. Biol. 3 (2007) 104
10. Chuang H.Y., Lee E., Liu Y.T., Lee D., and Ideker T. Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 3 (2007) 140
11. Sgambato A., Cittadini A., Faraglia B., and Weinstein I.B. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J. Cell Physiol. 183 1 (2000) 18-27
12. Aoki K., and Taketo M.M. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J. Cell Sci. 120 Pt. 19 (2007) 3327-3335
13. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., and Stratton M.R. A census of human cancer genes. Nat. Rev. Cancer 4 3 (2004) 177-183
14. Lin W.C., Lin F.T., and Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15 14 (2001) 1833-1844
15. Stanelle J., and Putzer B.M. E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol. Med. 12 4 (2006) 177-185
16. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 7015 (2004) 316-323
17. Morgan S.E., and Kastan M.B. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71 (1997) 1-25
18. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 5170 (1994) 346-355
19. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., O Gorman S., and Wahl G.M. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26 (2000) 37-43
20. Raycroft L., Wu H.Y., and Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249 4972 (1990) 1049-1051
21. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., and Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27 1 (1999) 29-34
22. Cavallaro U., and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4 2 (2004) 118-132
23. Nathke I. Relationship between the role of the adenomatous polyposis coli protein in colon cancer and its contribution to cytoskeletal regulation. Biochem. Soc. Trans. 33 Pt. 4 (2005) 694-697
24. Chene P. The role of tetramerization in p53 function. Oncogene 20 21 (2001) 2611-2617
25. Yoshida K., and Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95 11 (2004) 866-871
26. Powers J.T., Hong S.K., Mayhew C.N., Rogers P.M., Knudsen E.S., and Johnson D.G. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis 1 1 American Cancer Society (ES Knudsen) and NIH (grants CA98601, ES11047, ES07784, CA16672, and T32ESO7247). Mol. Cancer Res. 2 4 (2004) 203-214
27. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 8 (2004) 789-799
28. Hill M: http://embryology.med.unsw.edu.au/DNA/DNA10.htm. 1999.
29. Baasiri R.A., Glasser S.R., Steffen D.L., and Wheeler D.A. The breast cancer gene database: a collaborative information resource. Oncogene 18 56 (1999) 7958-7965
30. Yang Y., and Fu L.M. TSGDB: a database system for tumor suppressor genes. Bioinformatics 19 17 (2003) 2311-2312
31. Peruzzi F., Prisco M., Dews M., Salomoni P., Grassilli E., Romano G., Calabretta B., and Baserga R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell Biol. 19 10 (1999) 7203-7215
32. Riedemann J., and Macaulay V.M. IGF1R signalling and its inhibition. Endocr. Relat. Cancer 13 Suppl. 1 (2006) S33-S43
33. Resnik J.L., Reichart D.B., Huey K., Webster N.J., and Seely B.L. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res. 58 6 (1998) 1159-1164
34. Hamosh A., Scott A.F., Amberger J.S., Bocchini C.A., and McKusick V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33 Database issue (2005) D514-D517
35. Patterson M. Human genetics: affairs of the heart. Nature Rev. Genet. 2 (2001) 86
36. Franz W.M., Muller O.J., and Katus H.A. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358 9293 (2001) 1627-1637
37. Ahmad F., Seidman J.G., and Seidman C.E. The genetic basis for cardiac remodeling. Annu. Rev. Genomics Hum. Genet. 6 (2005) 185-216
38. Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T.A., Gregersen N., Hansen P.S., Baandrup U., and Borglum A.D. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103 10 (1999) R39-R43
39. Williams B.O., Remington L., Albert D.M., Mukai S., Bronson R.T., and Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7 4 (1994) 480-484
40. Wang L., Sun F., and Chen T. Prioritizing functional modules mediating genetic perturbations and their phenotypic effects: a global strategy. Genome Biol. 9 12 (2008) R174
41. Rhee S.Y., Wood V., Dolinski K., and Draghici S. Use and misuse of the gene ontology annotations. Nat. Rev. Genet. 9 7 (2008) 509-515
42. Jones S., Zhang X., Parsons D.W., Lin J.C.H., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., and Jimeno A. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science's STKE 321 5897 (2008) 1801
43. Parsons D.W., Jones S., Zhang X., Lin J.C.H., Leary R.J., Angenendt P., Mankoo P., Carter H., and Siu I. An integrated genomic analysis of human glioblastoma multiforme. Science 321 5897 (2008) 1807
44. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., and Ptak J. The genomic landscapes of human breast and colorectal cancers. Science 318 5853 (2007) 1108
45. Mishra G.R., Suresh M., Kumaran K., Kannabiran N., Suresh S., Bala P., Shivakumar K., Anuradha N., Reddy R., Raghavan T.M., et al. Human protein reference database-2006 update. Nucleic Acids Res. 34 Database issue (2006) D411-D414
46. Xing Y., Xu Q., and Lee C. Widespread production of novel soluble protein isoforms by alternative splicing removal of transmembrane anchoring domains. FEBS Lett. 555 3 (2003) 572-578
47. Yekutieli D., and Benjamini Y. Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J. Stat. Plan. Inference 82 1-2 (1999) 171-196
48. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57 1 (1995) 289-300
49. Pounds S., and Cheng C. Improving false discovery rate estimation. Bioinformatics 20 11 (2004) 1737-1745
50. Pluim J.P., Maintz J.B., and Viergever M.A. Mutual-information-based registration of medical images: a survey. IEEE Trans. Med. Imaging 22 8 (2003) 986-1004